DuPont announced the election of Ulf M. “Mark” Schneider, president and CEO of Fresenius SE & Co. KGaA to its board of directors, effective Oct. 22, 2014.
Schneider has served since 2003 as president and CEO for Fresenius SE & Co. KGaA, a diversified global health care group, with $27.0 billion in revenue in 2013.
Mark Schneider Elected to DuPont Board of Directors
Published August 22, 2014
blog comments powered by Disqus